MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Systematic Review of Non-pharmacological Interventions for Respiratory Health in Parkinson’s Disease (PD)

    L. Mcmahon, O. Lennon, C. Blake (Dublin, Ireland)

    Objective: This study systematically reviews randomized controlled trials (RCTs) and control trials of non-pharmacological interventions currently used to improve respiratory function/metrics for people with PD.…
  • 2019 International Congress

    Adrenergic Receptor Modulation of Non-Motor Symptoms in Parkinson’s Disease

    M. Rangwala, E. Hogg, E. Tan, H. Lu, A. Garland Becerra, M. Tagliati (Los Angeles, CA, USA)

    Objective: To analyze the correlation between the use of beta-blockers (BB) and the prevalence of non-motor symptoms in patients with Parkinson’s disease (PD). Background: In…
  • 2019 International Congress

    Decreased baroreflex sensitivity in Parkinson’s disease is associated with orthostatic hypotension

    P. Turcani, P. Valkovic, P. Siarnik, S. Sutovsky (Bratislava, Slovakia)

    Objective: To compare the baroreflex sensitivity (BRS) of Parkinson’s disease patients with those of an age-matched control population, and to determine BRS association with blood pressure,…
  • 2019 International Congress

    IMPACT OF PAIN ON STROKE AND HYPERTENSION AS COMORBIDITIES IN PARKINSON’S DISEASE

    V. Wijaya, R. Pinzon, A. Al Jody (Yogyakarta, Indonesia)

    Objective: This study aimed to report the prevalence and type of pain in patients with PD, and to determine the relationship between each type of…
  • 2019 International Congress

    Levodopa Effects on Visuospatial Working Memory in Parkinson’s Disease

    E. Bayram, I. Litvan, B. Wright, C. Grembowski, D. Harrington (La Jolla, CA, USA)

    Objective: To investigate the effects of levodopa on memory load and distractor resistance during visuospatial working memory (WM) in Parkinson’s disease (PD). Background: Visuospatial WM…
  • 2019 International Congress

    Visual hallucinations in Parkinson´s disease and amyloid burden: 18F-Flutemetamol PET-MRI study

    B. Fernández-Rodríguez, C. Gasca-Salas, R. Rodríguez-Rojas, P. Guida, D. Mata-Marín, I. Obeso-Martín, L. Vela, M. Garcerant-Tafur, L. García-Cañamaque, JA. Obeso (Móstoles, Spain)

    Objective: To compare amyloid distribution in patients with Parkinson´s disease (PD) with visual hallucinations (VH-p) and without (VH-n). Background: In patients with PD the prevalence…
  • 2019 International Congress

    Mild Cognitive Impairment in Parkinson’s disease in South Indian population – Development of a test battery and assessment of prevalence and characteristics

    S. Krishnan Nair, R. Ramesh, G. Sarma, D. Puthenveedu, R. Menon, A. Kishore (Thiruvananthapuram, India)

    Objective: We aimed to design a neuropsychological test battery to diagnose Mild Cognitive Impairment (MCI) and to estimate the prevalence of MCI in Malayalam-speaking patients…
  • 2019 International Congress

    Neuroprotective Effects of Combined Administration of Coenzyme Q10 and Vitamin-E in Chronic Cerebral Hypoperfusion-Induced Neurodegeneration in Rats

    WMY. Mohamed, MA. Alazimi (Kuantan, Malaysia)

    Objective: This study assessed the neuroprortective effects of combination of CoQ10 with vitamin E in Chronic Cerebral Hypoperfusion-induced neurodegeration (CCH-ND) model of rat. Background: Alzheimer’s…
  • 2019 International Congress

    Praxis deficits in patients with Parkinson’s disease: A neuropsychological study

    E. Rounis, G. Pizzamiglio (Oxford, United Kingdom)

    Objective: 1. To identify presence and subtypes of apraxia in patients with idiopathic Parkinson’s Disease. 2. To relate praxis deficits in IPD to clinical UPDRS,…
  • 2019 International Congress

    Prodromal symptoms in clinically diagnosed dementia with Lewy bodies stratified by Lewy body pathology on autopsy

    K. Wyman-Chick, D. Weintraub, M. Rosenbloom, L. Erickson, P. Martin, T. Barclay, M. Barrett (Bloomington, MN, USA)

    Objective: Compare prodromal neuropsychiatric, sleep, and motor symptoms in patients clinically diagnosed with dementia with Lewy bodies (DLB) with and without Lewy body pathology on…
  • « Previous Page
  • 1
  • …
  • 144
  • 145
  • 146
  • 147
  • 148
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley